The in vitro analysis of growth regulation in low-grade B non- (PAS). 6 In addition, low-grade B-NHL can be stimulated by T
Introduction was originally developed for stimulation of normal B cells, 16 was also used for activation of follicular lymphoma cells in Substantial progress has been made in the understanding of vitro with a transient cell proliferation in six samples tested. 17 the pathobiology in low-grade B non-Hodgkin's lymphoma In vitro the CD40L-dependent activation pathway can be (B-NHL). The follicular lymphoma is characterized at the molbypassed, since bone marrow stromal cells or fibroblasts ecular level by the translocation t (14;18) , which fuses the bclalone sufficiently prolonged survival of CLL cells by blocking 2 gene to the immunoglobulin heavy chain gene and leads apoptosis as described for normal and leukemic B cell precurto a preferential expression of the bcl-2 protein.
1,2 The bcl-2 sors in vitro. [18] [19] [20] The aim of our study was the precise analysis protooncogene, which stands in a dynamic equilibrium with of the influence of CDw32-transfected mouse fibroblasts, antiits heterodimeric partner and antagonist bax, inhibits CD40 antibodies mAb89 and EA-5, soluble recombinant apoptosis. Overexpression of the gene product leads to prohuman CD40 ligand gp39 and IL-4 on cell survival, apoptosis longed survival of the malignant cell clone. 3, 4 The immunocyand bcl-2 expression of follicular and immunocytic lymphoma toma are moleculargenetically more heterogenous. A high cells in vitro. correlation of this histological subtype was observed with the translocation t(9;14)(p13;q32), which targets the PAX-5 (paired homeobox-5) gene, a B cell-specific transcription factor involved in B cell proliferation and differentiation. 5 
Materials and methods
The analysis of cellular mechanisms, which regulate cell survival and proliferation of low-grade B-NHL was hampered in the past by the frustrating experience of propagating low- Data were statistically tested using the non-parametric Wilcoxon test (software PC-Statistik 2.12; TopSoft, Hannover, USA) was diluted 1:20 of the stem solution and used for stimulation assays. IL-4 (Genzyme, Germany) was used at Germany). Differences with P values Ͻ0.05 were considered statistically significant. 100 IU/ml. patients with immunocytoma and one sample of a patient with follicular lymphoma were assessed for cell viability on day 7. A mean of 4 × 10 4 /ml cells survived in the control compared Propidium iodide (PI) staining with a mean of 7.4 × 10 4 /ml surviving cells on the LTK − cells (data not shown). There was no significant difference in cell PI staining was performed as previously described. 21 Briefly, 5 × 10 4 B-NHL cells were washed in PBS once and gently survival on LTK − cells between B-NHL cells from patients with follicular lymphoma cells or patients with immunocytoma. In mixed with 1.5 ml hypotonic fluochrome solution consisting of 50 g PI/ml (Sigma, Deisenhofen, Germany) in 0.1% Triorder to exclude T cell proliferation, the surviving cell population was immunophenotyped with CD19-PE and CD3-FITC. ton-X (Sigma, Germany) and 0.1% sodium citrate. Cells were incubated overnight in the dark at 4°C and analyzed on a
Coculture assays

Results
Influence of LTK
All samples tested showed a homogenous CD19 + B cell popu- IL-4 + mAb89 2 2.5 ± 0.7 2 ± 0 2.5 ± 2.1 2.5 ± 0.7 10.5 ± 0.7 12 ± 1.4 3 1 ± 0 2 ± 1.4 1 ± 1.4 3 ± 2.8 9 ± 1.4 12 ± 4.2 12 0.5 ± 0.7 1 ± 1.4 1.5 ± 0.7 0.5 ± 0.7 8 ± 1.4 8 ± 0 14* 3 ± 1.4 1.5 ± 0.7 1 ± 0 0.5 ± 0.7 16 ± 2.8 16 ± 2.8 2.5 ± 10 5 B-NHL cells from three patients with follicular lymphoma and one patient with immunocytoma (*) were highly purified by FACS and cocultured with IL-4, mAb89, IL-4 plus mAb89, LTK − cells, LTK − cells plus IL-4 and mAb89 or in medium alone (control). Cell survival was quantified by trypan-blue exclusion on day 4. istically significant (P = 0.001). B-NHL cells in the control showed the cytomorphological signs of apoptosis, whereas cells on the feeder layer displayed nucleoli and abundant basophilic cytoplasm (Figure 2 ). In none of the samples was induction of S phase in the leukemic cell population by CDw32 fibroblasts seen in cell cycle analysis (data not shown).
MAb89 and IL-4 do not influence cell survival or (Table 1) . 4 plus mAb89; the CD40 system did not significantly enhance B-NHL lymphoma cells of six patients with follicular lymcell survival compared to LTK − cells alone. In addition, five phoma and two patients with immunocytoma were cocultured samples of patients with immunocytoma and one sample of with LTK − cells for 4 or 14 days. Apoptosis and cell cycle a patient with follicular lymphoma were cocultured as analysis was tested by PI staining. In all samples LTK − cells described above and were assessed for cell viability on day 7 efficiently blocked apoptosis of the B-NHL cells. Apoptotic with identical results (data not shown). Highly purified B-NHL cell death was reduced from a mean of 67% (range 40-98) in cells were neither stimulated by IL-4, mAb89 or IL-4 plus the control to 16% (5-46) on the fibroblasts (Table 2 ). The mAb89 as compared to the control nor by the CD40 system difference in apoptosis assessed after 4 days was highly statas compared to LTK − cells alone (Table 1) . Apoptosis was quantified on day 4 or 14 of the coculture. Neither IL-4 nor mAb89 further reduced apoptosis of the leu- Influence of the soluble recombinant human CD40 ligand gp39 on low-grade NHL cells
Purified B-NHL from four patients with follicular NHL and two patients with immunocytoma were incubated with the human soluble CD40 ligand gp39 alone, with gp39 plus the anti-CD40 antibody mAb89 or gp39 plus IL-4 for 6 days. In the six samples tested gp39 did not statistically significantly enhance cell viability compared to the control (Figure 4 ). In CLL cells 15 and follicular lymphoma cells. 17 Our data identify the LTK − cells as the essential element in the CD40 system. toma were cultured in medium alone (control), with IL-4 or with mAb89. Viability of controls decreased rapidly (Figure 1) .
The murine feeder cells alone prolonged significantly cell survival of the malignant B cells. The B-NHL cells displayed the IL-4 did not prevent the rapid death of the NHL cells although an increase in cell survival was observed. Coincubation with cytomorphology of viable, activated B cells on the murine fibroblasts. The data were confirmed by a highly significant mAb89 did not influence the survival of the B-NHL cells (data not shown). In five samples of patients with immunocytoma reduction of the apoptotic cell fraction. This agrees with the observation in B-CLL, that activation of the malignant cell and one sample of a patient with follicular lymphoma a potential synergism of the anti-CD40 mAb mAb89 and EA-5 in sticlone had an absolute requirement for the LTK − cells. 22, 23 In B-CLL it was shown that cell survival can be efficiently promulating B-NHL cells were analyzed on day 3 and day 7. On day 3 the two anti-CD40 mAbs alone or in combination had longed and apoptosis prevented by bone marrow human stro-
Figure 4
2.5 × 10 5 B-NHL cells/ml were cultured in medium alone (control), with gp39, with gp39 plus mAb89 or with gp39 plus IL-4. Cell viability was assessed by trypan-blue exclusion on day 6. Data represent the mean of two independent measurements. c, control; gp, gp39; 89, mAb89. mal cells. 18 As it is known for normal and malignant B cell with cell survival or cell death: IL-4 or LTK − cells as positive growth signals prevent loss of bcl-2 protein expression, 23, 27 precursors 19, 24 it can be postulated that the stroma feeder stimulates the malignant B cells by secretion of growth-prowhereas the growth inhibitory IL-10 downregulates bcl-2 in nonactivated B-CLL cells. 28 IL-4 and mAb89 did not further moting cytokines or by local compartmentalization of growth factors by stromal cell-associated extracellular matrix. The lead to elevated bcl-2 protein expression in LTK − -dependent cocultures, which is in agreement with our observation that murine LTK − cell line can substitute for the human stroma in B-CLL, 23 which implies a cross-species conservation of B cell maximal blockage of apoptosis was already achieved with LTK − cells alone. promoting mechanisms. This phenomenon is well known from in vitro culture of myeloid or lymphoid progenitors. 20, 25 Without LTK − cells only IL-4 was identified as a -however weak -stimulatory cytokine with a significant increase in cell A substantial cell fraction of the malignant B cells adhered to the murine fibroblasts (data not shown), which underlines the viability after 6 days incubation. IL-4 as IL-2 was described as a stimulatory cytokine for B-CLL and activated follicular importance of direct cell-cell contact between B cell and the feeder layer as was shown for B-CLL. 23 Although IL-4 and lymphoma cells, 8, 9, 23, 27, 29 which underlines the crucial importance of T cell-derived cytokines for the activation of lowmAb89 further activated the malignant B cells as shown by a significant increase of the forward and side scatter profile (data grade B-NHL cells in vitro. This supports the hypothesis that activated CD4 + T cells might contribute to cell survival of not shown), no cell expansion of the malignant B cell clone as an increase of the absolute number of viable cells was malignant B-NHL cells in vivo, stimulating the malignant B cell population by secreting IL-4 and IL-2 and by expression described in agreement with recent data. 26 This contrasts with the data of Johnson et al, 17 who observed transient cell expanof costimulatory signals as CD40L. In contrast the anti-CD40 antibodies mAb89 and EA-5 or the soluble recombinant sion of follicular lymphoma cells in the CD40 system.
Although the LTK − cell coculture system demonstrated a human CD40 ligand gp39 did not statistically significant prolong viability of the malignant B cells without costimulation high selection for survival of B cells and contamination of T cells were less than 3% it cannot be excluded that accessory by LTK − cells. This is in agreement with the observation that the optimal effect of the human CD40 ligand depends on the non-malignant cells as monocytes or T cells play a role in survival of the enriched lymphoma populations in the first culimmobilization or expression as membrane-associated ligand for stimulation of normal and malignant B cells. 30, 31 However, ture period. Therefore, three samples of patients with follicular lymphoma and a sample of a patient with immunocytoma in one sample, lymphoma cells showed improved survival when incubated with gp39 plus IL-4; in a second sample, surwere highly enriched by FACS sorting with a purity Ͼ98%. As shown for the enirched lymphoma samples LTK − cells vival was improved with gp39 plus mAb89, whereas gp39 plus IL-4 had no effect. This suggests a great heterogeneity efficiently supported cell survival of the lymphoma cells, dem- understand the pathobiology and to develop innovative thera- 
